|
|
|
|
|
|
|
|
|
|
|
|
|
27.03.26 - 15:00
|
Wave Life Sciences Slips as Obesity Data Fails to Convince (24/7 Wall St.)
|
|
|
Wave Life Sciences (NASDAQ:WVE) shares are trading near historic lows after two Wall Street firms cut their price targets following updated Phase 1 INLIGHT trial data for WVE-007, the company's obesity candidate. The stock fell nearly 50% on March 26, closing at $6.20 — its lowest level in over a year — as investors concluded ... Wave Life Sciences Slips as Obesity Data Fails to Convince
The post Wave Life Sciences Slips as Obesity Data Fails to Convince appeared first on 24/7 Wall St.....
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|